Ipilimumab/nivolumab

Thrombotic thrombocytopenic purpura: case report

    This is a preview of subscription content, access via your institution.

    Reference

    1. Lancelot M, et al. Refractory thrombotic thrombocytopenic purpura related to checkpoint inhibitor immunotherapy. Transfusion 61: 322-328, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1111/trf.16117

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ipilimumab/nivolumab. Reactions Weekly 1842, 217 (2021). https://doi.org/10.1007/s40278-021-90953-2

    Download citation